Gene Immunotherapy of Colon Carcinoma with IL-2 and IL-12 Using Gene Electrotransfer
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241612900 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Tilen Komel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Oncology, Institute of Oncology Ljubljana, Zaloska 2, SI-1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Colonic Neoplasms, Carcinoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research Agency, Slovenian Research and Innovation Agency (ARIS).
Abstract (Originalsprache)
Gene immunotherapy has become an important approach in the treatment of cancer. One example is the introduction of genes encoding immunostimulatory cytokines, such as interleukin 2 and interleukin 12, which stimulate immune cells in tumours. The aim of our study was to determine the effects of gene electrotransfer of plasmids encoding interleukin 2 and interleukin 12 individually and in combination in the CT26 murine colon carcinoma cell line in mice. In the in vitro experiment, the pulse protocol that resulted in the highest expression of IL-2 and IL-12 mRNA and proteins was used for the in vivo part. In vivo, tumour growth delay and also complete response were observed in the group treated with the plasmid combination. Compared to the control group, the highest levels of various immunostimulatory cytokines and increased immune infiltration were observed in the combination group. Long-term anti-tumour immunity was observed in the combination group after tumour re-challenge. In conclusion, our combination therapy efficiently eradicated CT26 colon carcinoma in mice and also generated strong anti-tumour immune memory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Oncology, Institute of Oncology Ljubljana, Zaloska 2, SI-1000 Ljubljana, Slovenia.
- Faculty of Medicine, University of Ljubljana, Vrazov trg 2, SI-1000 Ljubljana, Slovenia.
- Faculty of Medicine, Institute of Pathophysiology, University of Ljubljana, Zaloska 4, SI-1000 Ljubljana, Slovenia.
- Faculty of Health Sciences, University of Ljubljana, Zdravstvena pot 5, SI-1000 Ljubljana, Slovenia.
- Faculty of Health Sciences, University of Primorska, Polje 42, SI-6310 Izola, Slovenia.
ORCID-Profile: Urska Kamensek, Ursa Lampreht Tratar, Simona Kranjc Brezar, Klemen Dolinar, Sergej Pirkmajer, Gregor Sersa, Maja Cemazar
Förderung
- Slovenian Research Agency
- Slovenian Research and Innovation Agency (ARIS)
Zitieren
APA
Komel, T., Omerzel, M., Kamensek, U., Znidar, K., Lampreht Tratar, U., Kranjc Brezar, S., Dolinar, K., Pirkmajer, S., Sersa, G., & Cemazar, M. (2023). Gene Immunotherapy of Colon Carcinoma with IL-2 and IL-12 Using Gene Electrotransfer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241612900
Vancouver
Komel T, Omerzel M, Kamensek U, Znidar K, Lampreht Tratar U, Kranjc Brezar S, et al. Gene Immunotherapy of Colon Carcinoma with IL-2 and IL-12 Using Gene Electrotransfer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241612900
BibTeX
@article{Komel2023,
author = {Komel, Tilen and Omerzel, Masa and Kamensek, Urska and Znidar, Katarina and Lampreht Tratar, Ursa and Kranjc Brezar, Simona and Dolinar, Klemen and Pirkmajer, Sergej and Sersa, Gregor and Cemazar, Maja},
title = {Gene Immunotherapy of Colon Carcinoma with IL-2 and IL-12 Using Gene Electrotransfer},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241612900}
}
EUVIMED